Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Change in Cash: 2018-2024

Historic Change in Cash for Therapeutics (RAPT) over the last 7 years, with Dec 2024 value amounting to $122.3 million.

  • Therapeutics' Change in Cash rose 2080.40% to $131.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $122.3 million, marking a year-over-year increase of 1332.92%. This contributed to the annual value of $122.3 million for FY2024, which is 1332.92% up from last year.
  • Therapeutics' Change in Cash amounted to $122.3 million in FY2024, which was up 1,332.92% from $8.5 million recorded in FY2023.
  • Over the past 5 years, Therapeutics' Change in Cash peaked at $122.3 million during FY2024, and registered a low of -$52.5 million during FY2020.
  • In the last 3 years, Therapeutics' Change in Cash had a median value of $14.9 million in 2022 and averaged $48.6 million.
  • Its Change in Cash has fluctuated over the past 5 years, first tumbled by 486.20% in 2020, then spiked by 1,774.41% in 2022.
  • Over the past 5 years, Therapeutics' Change in Cash (Yearly) stood at -$52.5 million in 2020, then surged by 98.30% to -$891,000 in 2021, then skyrocketed by 1,774.41% to $14.9 million in 2022, then slumped by 42.81% to $8.5 million in 2023, then soared by 1,332.92% to $122.3 million in 2024.